Cited by 517Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., Perl, D. P.·1995·Archives of Neurology

DOI 10.1001/archneur.1995.00540250089017

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To determine the relationships between dementia severity and the extent of histopathologic lesions in a variety of brain regions. Neocortical and hippocampal ratings for neurofibrillary tangles (NFTs) and senile plaques (SPs) were compared in 70 cases of clinically and neuropathologically confirmed Alzheimer's disease. DESIGN: Neuropathologic case series. Dementia severity was assessed by postmortem chart review with use of the extended Clinical Dementia Rating Scale (CDR). Linear association between CDR scores and NFT and SP scores were assessed by partial correlation, controlling for age at death. SETTING: Studies were conducted at the Alzheimer's Disease Research Center of the Mount Sinai Medical Center, New York, NY. MAIN OUTCOME MEASURE: Association between CDR scores and neuropathologic changes assessed with the Consortium to Establish a Registry for Alzheimer's Disease semiquantitative scale. RESULTS: Among these lesion scores, only NFTs showed a significant association with CDR score, and only for neocortical regions. In particular, NFT densities in the superior temporal cortex were most strongly correlated with dementia severity, followed by those in the inferior parietal and midfrontal cortex. No such correlations were apparent for the amygdala, hippocampus, or entorhinal cortex. Medial temporal lobe structures displayed high NFT scores, even in cases of mild dementia. Senile plaques did not correlate significantly with CDR score in any region. CONCLUSIONS: These data support the notion that neocortical neuronal degeneration, as indicated by NFT formation, is a critical determinant of the clinical progression of Alzheimer's disease and suggest that medial temporal lobe structures may represent the initial site of NFT formation. While SP density correlates with age at death, there is no correlation between SP counts and dementia severity. These results further suggest that the clinical presentation of dementia may be closely related to neurodegeneration in neocortical regions within the temporal lobe.

Integrity signals

Registry

Crossref · 10.1001/archneur.1995.00540250089017

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380

Show all 40 references

Sorted by citations

Items 201–300 of 517

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
Khan, T. K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00275 · Cited by 56
Cerebral metabolic correlates of four dementia scales in Alzheimer’s disease
Salmon, É., Lespagnard, S., Marique, P.-X., Peeters, F., Herholz, K., Perani, D., Holthoff‐Detto, V., Kalbe, E., Anchisi, D., Adam, S., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0551-3 · Cited by 55
Apolipoprotein E ε4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease
Yasuda, M., Mori, E., Kitagaki, H., Yamashita, H., Hirono, N., Shimada, K., Maeda, K., & Tanaka, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.779 · Cited by 55
Structural basis of dementia in neurodegenerative disorders
Jellinger, K. A. (1996) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6892-9_1 · Cited by 54
Distinct destructive signal pathways of neuronal death in Alzheimer's disease
Shen, Y., He, P., Zhong, Z., McAllister, C. E., & Lindholm, K. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.002 · Cited by 53
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
Agadjanyan, M. G., Zagorski, K., Petrushina, I., Davtyan, H., Kazarian, K., Antonenko, M., Davis, J. L., Bon, C., Blurton-Jones, M. M., Cribbs, D. H., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0172-1 · Cited by 56
Molecular polymorphism of Aβ in Alzheimer's disease
LeVine, H., & Walker, L. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.026 · Cited by 54
A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals
Liu, P., Smith, B. R., Montonye, M. L., Kemper, L. J., Leinonen-Wright, K., Nelson, K. M., Higgins, L., Guerrero, C. R., Markowski, T. W., Zhao, X., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60777-x · Cited by 51
Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging
Krell‐Roesch, J., Rakuša, M., Syrjanen, J. A., van Harten, A. C., Lowe, V. J., Jack, C. R., Kremers, W. K., Knopman, D. S., Stokin, G. B., Petersen, R. C., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12557 · Cited by 51
Cholinergic dysfunction in vascular dementia
Román, G. C. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0019-2 · Cited by 51
Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation
Tranchant, C., Sergeant, N., Wattez, A., Mohr, M., Warter, J., & Delacourte, A. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.2.240 · Cited by 50
“End-Stage” Neurofibrillary Tangle Pathology in Preclinical Alzheimer's Disease: Fact or Fiction?
Abner, E. L., Kryscio, R. J., Schmitt, F. A., SantaCruz, K. S., Jicha, G. A., Lin, Y., Neltner, J. M., Smith, C. D., Van Eldik, L. J., & Nelson, P. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101980 · Cited by 49
Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease
Martínez‐Pinilla, E., Ordóñez, C., del Valle, E., Navarro, A., & Tolivia, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00213 · Cited by 49
Dementia spectrum disorders: lessons learnt from decades with PET research
Wilson, H., Pagano, G., & Politis, M. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01975-4 · Cited by 50
Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia
Laske, C., Stransky, E., Fritsche, A., Eschweiler, G. W., & Leyhe, T. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0838-3 · Cited by 48
Dementia of the Alzheimer type and related dementias in the aged: DAT subgroups and senile dementia of the neurofibrillary tangle type
Yamada, M., Itoh, Y., Otomo, E., Suematsu, N., & Matsushita, M. (1996) · Neuropathology · doi:10.1111/j.1440-1789.1996.tb00162.x · Cited by 47
Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease
Rosen, R. F., Tomidokoro, Y., Farberg, A. S., Dooyema, J., Ciliax, B., Preuss, T. M., Neubert, T. A., Ghiso, J. A., LeVine, H., & Walker, L. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.019 · Cited by 46
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Leko, M. B., Štrac, D. Š., Mück‐Šeler, D., Pivac, N., Stanić, G., Hof, P. R., & Šimić, G. (2014) · Croatian Medical Journal · doi:10.3325/cmj.2014.55.347 · Cited by 48
Self-citation
Dementia with Lewy bodies and Alzheimer's disease
Rosenberg, C. K., Cummings, T. J., Saunders, A. M., Widico, C., McIntyre, L. M., & Hulette, C. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100415 · Cited by 46
β-amyloid: The known unknowns
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
Cariddi, L. P., Mauri, M. F., Cosentino, M., Versino, M., & Marino, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113008 · Cited by 45
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
Bengoa‐Vergniory, N., Velentza‐Almpani, E., Silva, A. M., Scott, C., Vargas‐Caballero, M., Sastre, M., Wade‐Martins, R., & Alegre‐Abarrategui, J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01117-y · Cited by 48
Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain
Wheeler, J. M., McMillan, P. J., Strovas, T. J., Liachko, N. F., Amlie‐Wolf, A., Kow, R. L., Klein, R. L., Szot, P., Robinson, L., Guthrie, C. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aao6545 · Cited by 44
Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice
Zhou, S., Jin, F. J., Yan, F., Liu, J., Chen, M., Zhang, Y., Wei, S.-J., Jin, H. D., Nie, J., Fu, X.-L., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.344840 · Cited by 45
Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease
Thangavel, R., Sahu, S. K., Hoesen, G. W. V., & Zaheer, A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.037 · Cited by 44
Dendrimers in Alzheimer’s Disease: Recent Approaches in Multi-Targeting Strategies
Arbez‐Gindre, C., Steele, B. R., & Micha‐Screttas, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030898 · Cited by 46
Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau
Egroo, M. V., Riphagen, J. M., Ashton, N. J., Janelidze, S., Sperling, R. A., Johnson, K. A., Yang, H., Bennett, D. A., Blennow, K., Hansson, O., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02041-y · Cited by 46
Neurofibrillary tangle-bearing neurons have reduced risk of cell death in mice with Alzheimer’s pathology
Zwang, T. J., Sastre, E. D., Wolf, N., Ruiz-Uribe, N., Woost, B., Hoglund, Z., Fan, Z., Bailey, J., Nfor, L., Buée, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114574 · Cited by 48
Progress in Clinical Neurosciences: Cognitive Markers of Progression in Alzheimer's Disease
Behl, P., Stefurak, T. L., & Black, S. E. (2005) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003917 · Cited by 43
Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
Velázquez, R., Meechoovet, B., Ow, A., Foley, C., Shaw, A. Y., Smith, B. E., Oddo, S., Hulme, C., & Dunckley, T. L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01684-9 · Cited by 44
Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2
Galván, M., David, J., Delacourte, A., Luna, J., & Mena, R. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3409 · Cited by 43
Theta power responses in mild Alzheimer’s disease during an auditory oddball paradigm: lack of theta enhancement during stimulus processing
Caravaglios, G., Castro, G., Costanzo, E., Maria, G. D., Mancuso, D., & Muscoso, E. G. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0488-2 · Cited by 42
Infrared spectroscopy: A new diagnostic tool in Alzheimer disease
Griebe, M., Daffertshofer, M., Stroick, M., Syren, M., Ahmad‐Nejad, P., Neumaier, M., Backhaus, J., Hennerici, M. G., & Fatar, M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.075 · Cited by 42
Non-tau based neuronal degeneration in Alzheimer's disease — an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex
van de Nes, J. A. P., Nafe, R., & Schlote, W. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.043 · Cited by 42
Amyloid, Presenilins, and Alzheimer’s Disease
Gassen, G. V., & Annaert, W. G. (2003) · The Neuroscientist · doi:10.1177/1073858403252227 · Cited by 41
Reevaluating the Role of Vascular Changes in the Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia
Gold, G., Giannakopoulos, P., & Bouras, C. (1998) · European Neurology · doi:10.1159/000007968 · Cited by 40
Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
Šimić, G., Španić, E., Horvat, L. L., & Hof, P. R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.003 · Cited by 40
Self-citation
Strategies for Improving the Postmortem Neuropathological Diagnosis of Alzheimer’s Disease
Trojanowski, J. Q., Clark, C. M., Schmidt, M. L., Arnold, S. E., & LEE, V. M. ‐. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00075-4 · Cited by 39
Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease
Galpern, W. R., Triana‐Baltzer, G., Li, L., Kolen, K. V., Timmers, M., Haeverans, K., Janssens, L., Kolb, H. C., Nandy, P., Aida, K., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.163 · Cited by 38
Imaging Protein Misfolding in the Brain Using β-Sheet Ligands
Harada, R., Okamura, N., Furumoto, S., & Yanai, K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00585 · Cited by 41
Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets
Brokaw, D. L., Piras, I. S., Mastroeni, D., Weisenberger, D. J., Nolz, J., Delvaux, E., Serrano, G. E., Beach, T. G., Huentelman, M. J., & Coleman, P. D. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.022 · Cited by 38
PET Agents in Dementia: An Overview
van Waarde, A., Marcolini, S., Deyn, P. P. D., & Dierckx, R. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.008 · Cited by 39
Cognitive Impairment
Joshi, S., & Morley, J. E. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.05.014 · Cited by 38
Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease
Li, X., Han, J., Bujaranipalli, S., He, J., Kim, E. Y., Kim, H. Y., Im, J. H., & Cho, W. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114444 · Cited by 38
Moderate Environmental Enrichment Mitigates Tauopathy in a Neurofibrillary Tangle Mouse Model
Lahiani-Cohen, I., Lourbopoulos, A. I., Haber, E., Rozenstein‐Tsalkovich, L., Abramsky, O., Grigoriadis, N., & Rosenmann, H. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318221bfab · Cited by 37
Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
Almansoub, H. A. M. M., Tang, H. R., Wu, Y., Wang, D., Mahaman, Y. A. R., Wei, N., Almansob, Y. A. M., He, W., & Liu, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180868 · Cited by 39
Relationships Between Cognition and Neuropathological Tau in Alzheimer’s Disease Assessed by 18 F Flortaucipir PET
Devous, M. D., Fleisher, A., Pontecorvo, M. J., Lu, M., Siderowf, A. D., Navitsky, M. A., Kennedy, I. A., Southekal, S. S., Harris, T. S., & Mintun, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200808 · Cited by 38
Amyloid β peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology
Kar, S., & Quirion, R. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45018-8 · Cited by 37
Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37
Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study
Mufson, E. J., He, B., Ginsberg, S. D., Carper, B. A., Bieler, G. S., Crawford, F., Alvarez, V. E., Huber, B. R., Stein, T. D., McKee, A. C., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5368 · Cited by 35
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Wang, X., Smith, K. D. B., Pearson, M. S., Hughes, A. C., Cosden, M. L., Marcus, J., Hess, J. F., Savage, M. J., Rosahl, T. W., Smith, S. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195486 · Cited by 35
Translational gene mapping of cognitive decline
Wilmot, B., McWeeney, S. K., Nixon, R. R., Montine, T. J., Laut, J., Harrington, C. A., Kaye, J. A., & Kramer, P. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.008 · Cited by 35
Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment
Knezevic, D., Verhoeff, N. P. L. G., Hafizi, S., Strafella, A. P., Graff‐Guerrero, A., Rajji, T. K., Pollock, B. G., Houle, S., Rusjan, P., & Mizrahi, R. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17741395 · Cited by 38
Cortical Neuropathology in Aging and Dementing Disorders
Hof, P. R., Bouras, C., & Morrison, J. H. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_8 · Cited by 35
Self-citation
Neuropathological Changes in Aging Brain
Xekardaki, A., Kövari, E., Gold, G., Papadimitropoulou, A., Giacobini, E., Herrmann, F. R., Giannakopoulos, P., & Bouras, C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-08939-3_6 · Cited by 35
[18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia
Lee, H., Seo, S., Lee, S., Jeong, H. J., Woo, S., Lee, K., Lee, Y., Park, K. H., Heo, J., Yoon, C. W., et al. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000216 · Cited by 35
The influence of sex on limbic volume and perfusion in AD
Callen, D. J., Black, S. E., Caldwell, C. B., & Grady, C. L. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.011 · Cited by 34
Alterations of Cyclin dependent kinase 5 expression and phosphorylation in Amyloid precursor protein (APP)-transfected PC12 cells
Czapski, G. A., Gąssowska-Dobrowolska, M., Songin, M., Radecka, U. D., & Strosznajder, J. B. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.058 · Cited by 33
CSF tau correlates with CJD disease severity and cognitive decline
Cohen, O. S., Chapman, J., Korczyn, A. D., Warman-Alaluf, N., Nitsan, Z., Appel, S. A., Kahana, E., & Rosenmann, H. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12441 · Cited by 33
Decisive role of Reelin signaling during early stages of Alzheimer’s disease
Krstic, D., Pfister, S., Notter, T., & Knuesel, I. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.042 · Cited by 33
TBK1 interacts with tau and enhances neurodegeneration in tauopathy
Abreha, M. H., Ojelade, S. A., Dammer, E. B., McEachin, Z. T., Duong, D. M., Gearing, M., Bassell, G. J., Lah, J. J., Levey, A. I., Shulman, J. M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100760 · Cited by 33
Specificity and sensitivity of the Abeta oligomer ELISA
Klaver, A. C., Patrias, L. M., Finke, J. M., & Loeffler, D. A. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.12.001 · Cited by 33
Constructional Apraxia in Alzheimer’s Disease: Association with Occipital Lobe Pathology and Accelerated Cognitive Decline
Smith, M., Esiri, M. M., Barnetson, L. P. D., King, E., & Nagy, Z. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051270 · Cited by 33
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains
Pirttilä, T., Soininen, H. S., Mehta, P. D., Heinonen, O., Lehtimäki, T. J., Bogdanović, N., Paljärvi, L., Kim, K. S., Kosunen, O., Winblad, B. G., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00204-7 · Cited by 33
Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review
Vogrinc, D., Goričar, K., & Dolžan, V. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646901 · Cited by 32
Effects of concentrated ambient ultrafine particulate matter on hallmarks of Alzheimer’s disease in the 3xTgAD mouse model
Herr, D., Jew, K., Wong, C., Kennell, A., Gelein, R. M., Chalupa, D., Raab, A., Oberdörster, G., Olschowka, J. A., O’Banion, M. K., et al. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.03.010 · Cited by 34
The Morphologic and Neurochemical Basis of Dementia: Aging, Hierarchical Patterns of Lesion Distribution and Vulnerable Neuronal Phenotype
Hof, P. R., Giannakopoulos, P., Vickers, J. C., Bouras, C., & Morrison, J. H. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.2.97 · Cited by 32
Self-citation
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Cacabelos, R., Martínez-Iglesias, O. A., Cacabelos, N., Carrera, I., Corzo, L., & Naidoo, V. (2024) · Life · doi:10.3390/life14121555 · Cited by 33
The application of weighted gene co-expression network analysis in identifying key modules and hub genes associated with disease status in Alzheimer’s disease
Sun, Y., Lin, J., & Zhang, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.59 · Cited by 31
Distinct disruptions in Land's cycle remodeling of glycerophosphocholines in murine cortex mark symptomatic onset and progression in two Alzheimer's disease mouse models
Granger, M. W., Liu, H., Fowler, C., Blanchard, A. P., Taylor, M. W., Sherman, S., Xu, H., Le, W., & Bennett, S. A. L. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14560 · Cited by 32
Glial reaction in aging and Alzheimer's disease
Unger, J. W. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981001)43:1 · Cited by 103
Self-citation
Expression and regulation of the LIM-class homeobox generlim-1 in neuronal progenitors of the rat cerebellum
Hayes, W. P., Yangco, N., Chin, H. R., Mill, J. F., Pu, L. P., Taira, M., Dawid, I. B., & Gallo, V. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010201)63:3 · Cited by 7
Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
Mehan, S., Bhalla, S., Siddiqui, E. M., Sharma, N., Shandilya, A., & Khan, A. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s247153 · Cited by 29
Pathological Correlates of Cognitive Impairment in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age
Robinson, A., Davidson, Y. S., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180171 · Cited by 29
Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease
Lovell, M. A., Robertson, J. D., Buchholz, B. A., Xie, C., & Markesbery, W. R. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00281-0 · Cited by 29
Does β-amyloid plaque formation cause structural injury to neuronal processes?
Woodhouse, A., West, A. K., Chuckowree, J. A., Vickers, J. C., & Dickson, T. C. (2005) · Neurotoxicity Research · doi:10.1007/bf03033772 · Cited by 30
Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment
Hajjar, I. M., & Levey, A. I. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1001 · Cited by 28
Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice
Minami, S., Clifford, T. G., Hoe, H., Matsuoka, Y., & Rebeck, G. W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.014 · Cited by 28
Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease
Reiman, E. M., Caselli, R. J., Alexander, G. E., & Chen, K. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00006-8 · Cited by 28
Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer’s Disease Psychosis
Gomar, J. J., Tan, G., Halpern, J. H., Gordon, M. L., GREENWALD, B. S., & Koppel, J. L. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01850-z · Cited by 27
Imaging Biomarkers in Alzheimer’s Disease: A Practical Guide for Clinicians
Sheikh‐Bahaei, N., Sajjadi, S. A., Manavaki, R., & Gillard, J. H. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170013 · Cited by 29
Treatment of mild cognitive impairment: rationale, present and future strategies
Jelić, V., & Winblad, B. G. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.12.x · Cited by 27
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Seo, E. H., Lim, H. J., Yoon, H., Choi, K. Y., Lee, J. J., Park, J. Y., Choi, S. H., Kim, H., Kim, B. C., & Lee, K. H. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00909-1 · Cited by 26
Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
Tashima, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020411 · Cited by 27
Selenium-Derivative Compounds: A Review of New Perspectives in the Treatment of Alzheimer’s Disease
Barbosa, F. A. R., Canto, R. F. S., Teixeira, K. F., de Souza, A. S., de Oliveira, A. S., & Braga, A. L. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220224161454 · Cited by 26
Knowing Me, Knowing You: Can a Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease?
Sutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 26
Deciphering Alzheimer’s Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR
de la Torre, J. C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201165 · Cited by 28
Luteinizing-hormone Releasing Hormone Therapy and the Risk of Death From Alzheimer Disease
D'Amico, A. V., Braccioforte, M. H., Moran, B. J., & Chen, M. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31819cb8f4 · Cited by 25
Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia
Sheikh‐Bahaei, N., Sajjadi, S. A., & Pierce, A. L. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0484-z · Cited by 28
Reduced insulin‐induced phosphatidylinositol‐3‐kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease
Castri, P., Iacovelli, L., Blasi, A. D., Giubilei, F., Moretti, A., Capone, F. T., Nicoletti, F., & Orzi, F. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05869.x · Cited by 24
Alzheimer’s disease
Reiman, E. M., & Caselli, R. J. (1999) · Maturitas · doi:10.1016/s0378-5122(98)00110-8 · Cited by 24
Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer’s disease pathology in Down syndrome
Maxwell, A. M., Yuan, P., Rivera, B. M., Schaaf, W., Mladinov, M., Prasher, V. P., Robinson, A. C., DeGrado, W. F., & Condello, C. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01298-0 · Cited by 23
Zinc utilization by microglia in Alzheimer’s disease
Shippy, D. C., Oliai, S. F., & Ulland, T. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107306 · Cited by 25
Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders
Martínez‐Viturro, C. M., Trabanco, A. A., Royes, J., Fernández, E., Tresadern, G., Vega, J. A., del Cerro, A., Delgado, F., Molina, A. G., Tovar, F., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01479 · Cited by 23
Heparan Sulfate Proteoglycans in Tauopathy
Zhu, Y., Gandy, L. A., Zhang, F., Liu, J., Wang, C., Blair, L. J., Linhardt, R. J., & Wang, L. (2022) · Biomolecules · doi:10.3390/biom12121792 · Cited by 27
Maladie d'Alzheimer
Delacourte, A., Campion, D., & Davous, P. (2007) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(07)44093-3 · Cited by 23
Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects
Hsiao, I., Lin, K., Huang, K., Huang, C., Chen, H.-S., Wey, S., Yen, T., Okamura, N., & Hsu, J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.189126 · Cited by 23
Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion
Pilliod, J., Desjardins, A., Pernègre, C., Jamann, H., Larochelle, C., Fon, E. A., & Leclerc, N. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013553 · Cited by 25
Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality
Rashid, U., & Ansari, F. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50002-7 · Cited by 23
Building a More Perfect Beast
Dickson, D. W. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63202-6 · Cited by 23

Authors: Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
ORCID: Hof, P. R.
Purohit, D. P.
Schmeidler, J.
Davis, K. L.
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 1995-01-01
Volume: 52
Issue: 1
Pages: 81-88
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneur.1995.00540250089017
OpenAlex: W2084957666
Cited by: 514
References: 40
Citations by year: 2026: 7 · 2025: 16 · 2024: 15 · 2023: 22 · 2022: 24 · 2021: 27 · 2020: 21 · 2019: 25 · 2018: 23 · 2017: 17 · 2016: 20 · 2015: 17 · 2014: 18 · 2013: 14 · 2012: 14
FWCI: 10.16
Type: journal article
Language: en
Open access: closed
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (AG-02219, AG 05138, P50AG005138, AG-00408, P01AG002219)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, neurofibrillary tangles, dementia severity, amyloid plaques, neocortex, hippocampus, medial temporal lobe, superior temporal cortex, inferior parietal cortex, Clinical Dementia Rating, neuropathology, neurodegeneration, clinical progression
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Female, Humans, Male, Middle Aged, Neurofibrillary Tangles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks